Ray Dalio's GMED Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 284,250 shares of Globus Medical, Inc. (GMED) worth $24.82 M, representing 0.09% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in GMED, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 303,527 shares. Largest reduction occurred in Q4 2025, reducing 176,841 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -176,841 | Reduce 38.35% | 284,250 | $87.31 |
| Q3 2025 | +24,452 | Add 5.60% | 461,091 | $57.27 |
| Q2 2025 | +303,527 | Add 228.02% | 436,639 | $59.02 |
| Q1 2025 | +133,112 | New Buy | 133,112 | $73.20 |
| Q4 2024 | -32,853 | Sold Out | 0 | $0.00 |
| Q3 2024 | -96,509 | Reduce 74.60% | 32,853 | $71.54 |
| Q2 2024 | +98,389 | Add 317.66% | 129,362 | $68.49 |
| Q1 2024 | -78,316 | Reduce 71.66% | 30,973 | $53.64 |
| Q4 2023 | -32,447 | Reduce 22.89% | 109,289 | $53.29 |
| Q3 2023 | +56,425 | Add 66.14% | 141,736 | $49.65 |
| Q2 2023 | -8,839 | Reduce 9.39% | 85,311 | $59.54 |
| Q1 2023 | +3,321 | Add 3.66% | 94,150 | $56.64 |
| Q4 2022 | -30,612 | Reduce 25.21% | 90,829 | $74.27 |
| Q3 2022 | -3,779 | Reduce 3.02% | 121,441 | $59.57 |
| Q2 2022 | +11,734 | Add 10.34% | 125,220 | $56.14 |
| Q1 2022 | +26,807 | Add 30.93% | 113,486 | $73.78 |
| Q4 2021 | -5,237 | Reduce 5.70% | 86,679 | $72.20 |
| Q3 2021 | -7,504 | Reduce 7.55% | 91,916 | $76.62 |
| Q2 2021 | +99,420 | New Buy | 99,420 | $77.53 |
Ray Dalio's Globus Medical Investment FAQs
Ray Dalio first purchased Globus Medical, Inc. (GMED) in Q2 2021, acquiring 99,420 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Globus Medical, Inc. (GMED) for 19 quarters since Q2 2021.
Ray Dalio's largest addition to Globus Medical, Inc. (GMED) was in Q2 2025, adding 436,639 shares worth $25.77 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 284,250 shares of Globus Medical, Inc. (GMED), valued at approximately $24.82 M.
As of the Q4 2025 filing, Globus Medical, Inc. (GMED) represents approximately 0.09% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Globus Medical, Inc. (GMED) was 461,091 shares, as reported at the end of Q3 2025.